Literature DB >> 28369180

Possible Interaction Between Cigarette Smoking and HLA-DRB1 Variation in the Risk of Follicular Lymphoma.

Fredrik Baecklund1, Jia-Nee Foo2, Johan Askling3,4, Sandra Eloranta5, Ingrid Glimelius6,7, Jianjun Liu8, Henrik Hjalgrim9, Richard Rosenquist10, Leonid Padyukov11, Karin E Smedby12.   

Abstract

Follicular lymphoma (FL) risk is strongly associated with germline genetic variation in human leukocyte antigen (HLA) class II. Cigarette smoking has been suggested to increase FL risk, primarily among women. We hypothesized that amino acids in HLA-antigen D-related β1 subunit (DRB1) interact with smoking in FL risk, as shown for rheumatoid arthritis. We analyzed 373 patients with FL and 818 controls from 2 population-based case-control studies in Sweden and Denmark (1999-2003). Haplotypes in HLA-DRB1 were imputed at amino acid positions 11, 13, 28, 30, and 70-74 (shared epitope). We estimated the relative risk of FL as odds ratios with 95% confidence intervals for different smoking status/haplotype combinations. Interaction was defined as departure from additivity of effects and quantified by the attributable proportion (AP). Relative to never-smokers carrying no shared epitope alleles, smoking was associated with the risk of FL among all subjects (for former smokers, odds ratio (OR) = 2.20, 95% confidence interval (CI): 1.10, 4.41; ORcurrent = 3.56, 95% CI: 1.60, 7.92) and women (ORformer = 2.95, 95% CI: 1.18, 7.37; ORcurrent = 5.63, 95% CI: 2.07, 15.3) carrying 2 shared epitope alleles but not among those carrying zero or 1 shared epitope allele. Smoking and shared epitope status interacted significantly as measured by AP (overall, AP = 0.6, 95% CI: 0.15, 1.0; for women, AP = 0.5, 95% CI: 0.005, 1.0). These results suggest a possible interaction between smoking and HLA-DRB1-associated antigen presentation in FL risk and provide a model to further unravel FL etiology.
© The Author 2017. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HLA-DRB1; etiology; follicular lymphoma; interaction; smoking

Mesh:

Substances:

Year:  2017        PMID: 28369180     DOI: 10.1093/aje/kww118

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  5 in total

1.  Associations between Smoking and Alcohol and Follicular Lymphoma Incidence and Survival: A Family-Based Case-Control Study in Australia.

Authors:  Michael K Odutola; Marina T van Leeuwen; Jennifer Turner; Fiona Bruinsma; John F Seymour; Henry M Prince; Samuel T Milliken; Judith Trotman; Emma Verner; Campbell Tiley; Fernando Roncolato; Craig R Underhill; Stephen S Opat; Michael Harvey; Mark Hertzberg; Geza Benke; Graham G Giles; Claire M Vajdic
Journal:  Cancers (Basel)       Date:  2022-05-30       Impact factor: 6.575

Review 2.  [Lymphoma in rheumatic diseases].

Authors:  A Rubbert-Roth; J T Bittenbring; G Assmann
Journal:  Z Rheumatol       Date:  2017-10       Impact factor: 1.372

3.  Pooled analysis of the HLA-DRB1 by smoking interaction in Parkinson disease.

Authors:  Yu-Hsuan Chuang; Pei-Chen Lee; Tim Vlaar; Claire Mulot; Marie-Anne Loriot; Johnni Hansen; Christina M Lill; Beate Ritz; Alexis Elbaz
Journal:  Ann Neurol       Date:  2017-10-26       Impact factor: 10.422

4.  Population-based epidemiological data of follicular lymphoma in Poland: 15 years of observation.

Authors:  Anna Szumera-Ciećkiewicz; Urszula Wojciechowska; Joanna Didkowska; Jan Poleszczuk; Grzegorz Rymkiewicz; Ewa Paszkiewicz-Kozik; Kamil Sokół; Monika Prochorec-Sobieszek; Jan Walewski
Journal:  Sci Rep       Date:  2020-09-03       Impact factor: 4.379

Review 5.  Current Understanding of an Emerging Role of HLA-DRB1 Gene in Rheumatoid Arthritis-From Research to Clinical Practice.

Authors:  Tomasz Wysocki; Marzena Olesińska; Agnieszka Paradowska-Gorycka
Journal:  Cells       Date:  2020-05-02       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.